IMA opposes proposed one year pharmacology course for non MBBS doctors
Alleges that the real problem is infrastructure not availability of doctors
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Zydus and IDRI sign agreement
Zydus & IDRI will collaborate to conduct clinical development activities in India for visceral leishmaniasis (Kala-Azar)
Piramal Enterprises receives IND approval from US FDA
P7435 is a novel DGAT1 inhibitor for treatment of lipid disorders and diabetes
Increasing product pipelines in acute care environment drive M&A activity
Witnesses no deals during July 2013
BIORx launches BIO-Accelerator Programme
Programme is devised for working executives, Ph.d scholars and post-doctoral scientists aspiring to accelerate the path of their…
Intelpack-2013: a must attend event
Over 175+ exhibitors from across nine countries will showcase the latest in packaging technology at the event
Local Organising Committee of 65th IPC felicitates Atul Kumar Nasa, President, IPCA
In the run up to the 65th IPC in December this year, the IPCA held its second local organising committee meeting to felicitate its…
The rise of the orphans
They might target small patient populations, but that hasn't deterred orphan drugs from making their impact felt. No wonder then…
’Piramal Enterprises’ diagnostic division business is expected to touch Rs…
M Neelam Kachhap speaks to Vijay Shah, Executive Director and COO, Piramal Enterprises to track the growth path
IPA to partner with state pharmacist associations
Associations from Karnataka, Kerala and Goa to be affiliated
UCB sues 15 companies over epilepsy drug Vimpat
According to IMS Health data for the 12 months ending March 31, 2013, Vimpat tablets and Solution had total US sales of…
Sun Pharma announces US FDA approval for generic Prandin tabs
Company has 180-day marketing exclusivity
Lupin receives FDA approval for generic Glumetza ER tabs
Is indicated as adjunct to diet and exercise to improve glycemic control in adults with type-2 diabetes mellitus
Cipla India completes accquisition of Cipla Medpro SA
The acquisition aims to strengthen Cipla’s commitment to South Africa and the broader African continent
Novartis, Biological E sign agreement to protect against typhoid and paratyphoid fevers
License agreement advances a Novartis goal to deliver accessible and affordable vaccines that address unmet medical need in…
Venus gets GMP approval from Ukraine for nine manufacturing facilities
The recognition has opened more opportunities for Venus Remedies, to expand its product portfolio in the remaining Pharmaceutical…
MSD, Lupin announce strategic partnership
To co-market MSD's 23-valent pneumococcal polysaccharide vaccine for Indian market
Speakers at Nasal and Pulmonary Drug Delivery symposium to discuss global regulatory trends
Scheduled to present at the event, Dr Amit Misra, Scientist and Associate Professor AcSIR, CSIR-CDRI and Dr Julie Suman,…
Pharma Tech Expo 2013 to be held in Indore from Oct 6-8, 2013
Will be a great opportunity for machinery and equipment suppliers to showcase their products
IPM grows 4.8 per cent in June, valued at Rs 5899 crores
Nine therapies have outgrown the IPM growth